BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24569946)

  • 1. Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British Columbia.
    Lee B; Goktepe O; Hay K; Connors JM; Sehn LH; Savage KJ; Shenkier T; Klasa R; Gerrie A; Villa D
    Oncologist; 2014 Mar; 19(3):283-90. PubMed ID: 24569946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study.
    Ritter AJ; Goldstein JS; Ayers AA; Flowers CR
    Leuk Lymphoma; 2019 Jul; 60(7):1656-1667. PubMed ID: 30632824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
    Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
    Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urban and rural differences in outcomes of head and neck cancer.
    Kim JD; Firouzbakht A; Ruan JY; Kornelsen E; Moghaddamjou A; Javaheri KR; Olson RA; Cheung WY
    Laryngoscope; 2018 Apr; 128(4):852-858. PubMed ID: 28940575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
    Griffiths R; Gleeson M; Knopf K; Danese M
    BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Travel Distance and Urban-Rural Status on the Multidisciplinary Management of Rectal Cancer.
    Loree JM; Javaheri KR; Lefresne SV; Speers CH; Ruan JY; Chang JT; Brown CJ; Kennecke HF; Olson RA; Cheung WY
    J Rural Health; 2017 Sep; 33(4):393-401. PubMed ID: 27717002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse.
    Villa D; Connors JM; Sehn LH; Gascoyne RD; Savage KJ
    Haematologica; 2011 Jul; 96(7):1002-7. PubMed ID: 21486867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world costing analysis for diffuse large B-cell lymphoma in British Columbia.
    Costa S; Scott DW; Steidl C; Peacock SJ; Regier DA
    Curr Oncol; 2019 Apr; 26(2):108-113. PubMed ID: 31043812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining palliative care program use and place of death in rural and urban contexts: a Canadian population-based study using linked data.
    Lavergne MR; Lethbridge L; Johnston G; Henderson D; D'Intino AF; McIntyre P
    Rural Remote Health; 2015; 15(2):3134. PubMed ID: 26103433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between race and survival in pediatric patients with diffuse large B-cell lymphoma.
    Khullar K; Plascak JJ; Drachtman R; Cole PD; Parikh RR
    Cancer Med; 2021 Feb; 10(4):1327-1334. PubMed ID: 33503323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain cancer survival in Canada 1996-2008: effects of sociodemographic characteristics.
    Walker EV; Ross J; Yuan Y; Smith TR; Davis FG
    Curr Oncol; 2019 Jun; 26(3):e292-e299. PubMed ID: 31285671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects.
    Smyth L; Blunt DN; Gatov E; Nagamuthu C; Croxford R; Mozessohn L; Cheung MC
    Br J Haematol; 2020 Nov; 191(3):396-404. PubMed ID: 32304100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
    Tao R; Allen PK; Rodriguez A; Shihadeh F; Pinnix CC; Arzu I; Reed VK; Oki Y; Westin JR; Fayad LE; Medeiros LJ; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):122-9. PubMed ID: 25754633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
    Sehn LH; Donaldson J; Chhanabhai M; Fitzgerald C; Gill K; Klasa R; MacPherson N; O'Reilly S; Spinelli JJ; Sutherland J; Wilson KS; Gascoyne RD; Connors JM
    J Clin Oncol; 2005 Aug; 23(22):5027-33. PubMed ID: 15955905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study.
    Kim J; Macharia PM; McCormack V; Foerster M; Galukande M; Joffe M; Cubasch H; Zietsman A; Anele A; Offiah S; Parham G; Pinder LF; Anderson BO; Schüz J; Dos Santos-Silva I; Togawa K
    Lancet Glob Health; 2024 Jul; 12(7):e1111-e1119. PubMed ID: 38788756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.
    El-Galaly TC; Villa D; Alzahrani M; Hansen JW; Sehn LH; Wilson D; de Nully Brown P; Loft A; Iyer V; Johnsen HE; Savage KJ; Connors JM; Hutchings M
    Am J Hematol; 2015 Nov; 90(11):1041-6. PubMed ID: 26260224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia.
    Slack GW; Steidl C; Sehn LH; Gascoyne RD
    Br J Haematol; 2014 Dec; 167(5):608-17. PubMed ID: 25135752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency.
    Ramadan KM; Shenkier T; Sehn LH; Gascoyne RD; Connors JM
    Ann Oncol; 2007 Jan; 18(1):129-135. PubMed ID: 17018705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in birth outcomes by neighborhood income: temporal trends in rural and urban areas, british columbia.
    Luo ZC; Kierans WJ; Wilkins R; Liston RM; Mohamed J; Kramer MS;
    Epidemiology; 2004 Nov; 15(6):679-86. PubMed ID: 15475716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study.
    Wästerlid T; Mohammadi M; Smedby KE; Glimelius I; Jerkeman M; Bottai M; Eloranta S
    J Intern Med; 2019 Apr; 285(4):455-468. PubMed ID: 30368947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.